Abstract:RAG endonuclease initiates V(D)J recombination by binding to the recombination signal sequences (RSSs), introducing DNA breaks between two V(D)J gene segments, and mediating their joining. This process is tightly regulated to generate diverse antigen receptor repertoires and prevent aberrant events that could cause genomic translocations/deletions and lymphoid cancer. RAG can track directionally over chromosomal loop domain in which they reside. Tracking is evidenced by cleavage/joining of short cryptic RSSs lying exclusively in convergent orientation to a bona fide RSS. However, the mechanism of RAG tracking and its impacts remain unknown. Here I established an unbiased assay system by utilizing allele-specific barcode and employing high throughput genome-wide translocation sequencing (HTGTS) to quantitatively evaluate RAG-mediated recombination frequency. I found that insertion of one single bona fide RSS is sufficient to initiate RAG tracking in the c-Myc domain and the recombination between the RSS and its cryptic RSSs seems to follow the 12/23 rule to some degree. When ectopically inserted bona fide RSS pair is 0.5kb apart, convergent configuration of the RSS pair is 4.8-fold more frequent than the tandem configuration. When the distance increases to 267kb, the difference increases to 14-fold, suggesting the contribution of RAG tracking over diffusion-based mechanism increases when the distance between RSS pair increases. In addition, the presence of CTCF-binding element promotes recombination by more than 10-fold. Depletion of Wapl, cohesin remover, to disrupt cohesin turnover reduces V(D)J recombination. The distal RSSs are much preferentially affected. The data suggest that RAG tracking may be driven by cohesin sliding along chromatin. Citation Format: Cheng-Sheng Lee, Jiazhi Hu, Frederick W. Alt. Elucidating the mechanism of RAG tracking and its impacts on V(D)J recombination [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr B171.

Cloning and characterization of the human recombination activating gene 1 (RAG1) and RAG2 promoter regions.

RAG gene and B cell lymphoma

Cloning of shark RAG2 and characterization of the RAG1/RAG2 gene locus

RAG1 targeting in the genome is dominated by chromatin interactions mediated by the non-core regions of RAG1 and RAG2

Collaboration of RAG2 with RAG1-like proteins during the evolution of V(D)J recombination

RAG2 Abolishes RAG1 Aggregation to Facilitate V(D)J Recombination.

The recombination activating genes, RAG 1 and RAG 2, are on chromosome 11p in humans and chromosome 2p in mice

Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype

The RAG1 N-terminal region regulates the efficiency and pathways of synapsis for V(D)J recombination

Expression of the RAG-2 gene in murine central nervous system tumor cell lines

Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences

RAG2 localization and dynamics in the pre-B cell nucleus

RAG-1-deficient mice have no mature B and T lymphocytes

Abstract B171: Elucidating the Mechanism of RAG Tracking and Its Impacts on V(D)J Recombination

Abstract B122: Molecular mechanism of V(D)J recombination from synaptic RAG1-RAG2 complex structures

An interdomain boundary in RAG1 facilitates cooperative binding to RAG2 in formation of the V(D)J recombinase complex

Nucleolar localization of RAG1 modulates V(D)J recombination activity

Dual role of RAG2 in V(D)J recombination: catalysis and regulation of ordered Ig gene assembly

Genome-Wide Analysis Identifies Rag1 and Rag2 as Novel Notch1 Transcriptional Targets in Thymocytes

A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement.

Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells